Owlstone Medical stock price, funding rounds, valuation and financials

Owlstone Medical has raised $66.51 m in total funding. Owlstone Medical annual revenue was £2.63 m in FY 2018

£2.6 M

Owlstone Medical Revenue FY, 2018
Owlstone Medical Gross profit (FY, 2018)1.8 M
Owlstone Medical Gross profit margin (FY, 2018), %67.8%
Owlstone Medical Net income (FY, 2018)-7.9 M
Owlstone Medical EBIT (FY, 2018)-9.5 M
Owlstone Medical Cash, 31-Dec-201836.6 M

Owlstone Medical Revenue

Owlstone Medical revenue was £2.63 m in FY, 2018

Embed Graph

Owlstone Medical Funding

Summary Metrics

Founding Date

2004

Owlstone Medical total Funding

$66.5 m

Owlstone Medical latest funding size

$35 m

Time since last funding

2 years ago

Owlstone Medical investors

Owlstone Medical's latest funding round in October 2018 was reported to be $35 m. In total, Owlstone Medical has raised $66.5 m

Owlstone Medical Revenue Breakdown

Embed Graph

Owlstone Medical revenue breakdown by business segment: 69.3% from Services and 30.7% from Product

Owlstone Medical revenue breakdown by geographic segment: 9.3% from UK, 8.3% from Rest of Europe, 79.8% from USA and 2.6% from Other

Owlstone Medical Income Statement

Annual

GBPFY, 2015FY, 2016FY, 2017FY, 2018

Revenue

4.4m2.0m1.8m2.6m

Revenue growth, %

(53%)(14%)

Cost of goods sold

1.6m691.0k561.7k847.6k

Gross profit

2.8m1.4m1.2m1.8m

Gross profit Margin, %

64%66%68%68%

Operating expense total

4.0m5.7m7.4m

Depreciation and amortization

458.9k

EBIT

(1.2m)(4.3m)(6.2m)(9.5m)

EBIT margin, %

(28%)(212%)(353%)(361%)

Interest expense

8.3k6.2k169.0346.0

Interest income

62.0750.01.1k39.7k

Pre tax profit

(1.2m)(4.3m)(6.2m)(9.5m)

Income tax expense

(495.7k)(671.8k)(1.0m)(1.6m)

Net Income

(37.7k)(3.7m)(5.2m)(7.9m)

Owlstone Medical Balance Sheet

Annual

GBPFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

129.1k54.5k39.0k4.5k1.3k38.2k8.1m1.8m36.6m

Accounts Receivable

181.0k356.1k253.6k271.4k582.1k165.2k411.4k470.6k2.1m

Prepaid Expenses

114.0k178.7k223.4k

Inventories

195.6k325.3k282.3k363.3k617.7k667.7k558.6k495.0k413.0k

Current Assets

505.8k736.0k574.9k639.2k1.2m1.6m10.1m4.9m41.2m

PP&E

135.5k274.6k242.5k555.1k436.2k517.6k627.9k999.6k1.6m

Total Assets

1.8m2.3m10.9m6.2m43.4m

Accounts Payable

499.6k917.4k777.5k1.1m1.7m(954.2k)(602.0k)(943.7k)556.0k

Short-term debt

Current Liabilities

957.3k917.4k777.5k1.1m1.7m(1.8m)(1.0m)(1.4m)1.6m

Long-term debt

Non-Current Liabilities

27.5k34.8k19.7k26.6k(60.7k)(30.2k)(20.0k)21.5k

Total Debt

Total Liabilities

1.7m(1.8m)(1.1m)(1.4m)1.6m

Common Stock

501.0502.0503.0504.0505.0505.0723.0729.01.1k

Additional Paid-in Capital

12.4m25.9m25.9m

Retained Earnings

(6.4m)(7.1m)(8.4m)(10.2m)(12.3m)(12.7m)(16.4m)(21.6m)(29.4m)

Total Equity

(132.4k)245.4k181.1k295.2k112.7k475.1k9.9m4.9m41.8m

Financial Leverage

16 x4.9 x1.1 x1.3 x1 x

Owlstone Medical Cash Flow

Annual

GBPFY, 2015FY, 2016FY, 2017FY, 2018

Net Income

4.4m(3.7m)(5.2m)

Depreciation and Amortization

166.0k238.1k308.3k

Accounts Receivable

175.6k(360.7k)(151.9k)

Inventories

50.0k109.1k63.6k

Accounts Payable

102.3k(734.2k)336.2k

Cash From Operating Activities

(474.3k)(4.3m)(5.5m)(8.7m)

Purchases of PP&E

(243.0k)(313.5k)(650.5k)

Cash From Investing Activities

(248.6k)(401.4k)(817.2k)(1.2m)

Cash From Financing Activities

759.8k12.7m(163.0)44.6m

Net Change in Cash

36.9k8.1m(6.3m)34.6m

Interest Paid

(8.3k)(6.2k)(169.0)

Owlstone Medical Ratios

GBPFY, 2010

Owlstone Medical Operating Metrics

FY, 2016FY, 2017Mar, 2019

Clinical Trials Sites

26

Diagnostic Outcomes to Date

218 1.52 k

Patients Recruited in Clinical Trials to Date

583 1.77 k

Patients Recruited in Clinical Trials, InTERCEPT

1.40 k

Patients Recruited in Clinical Trials, LuCID

4 k

Products

4

Owlstone Medical Human Capital

Job Roles

FY, 2017FY, 2016FY, 2015
Product Research and Development 66.7 %68.1 %66.7 %
Other33.3 %31.9 %33.3 %